Second Opinion
Orphan drugs to treat rare disease
Orphan drugs are often exceedingly expensive which beg the question of how much should we pay for a drug and how do we measure effectiveness?
Orphan drugs are often exceedingly expensive which beg the question of how much should we pay for a drug and how do we measure effectiveness?